This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2024 Nov 18;109(12):e2350-e2351.

doi: 10.1210/clinem/dgae218.

Redefining Actionable Disease in Well-differentiated Thyroid Cancer Management

Samantha K Newman¹, Robert Michael Tuttle¹

Affiliations

PMID: 38571308
DOI: 10.1210/clinem/dgae218

Editorial

Redefining Actionable Disease in Well-differentiated Thyroid Cancer Management

Samantha K Newman et al. J Clin Endocrinol Metab. 2024.

. 2024 Nov 18;109(12):e2350-e2351.

doi: 10.1210/clinem/dgae218.

Authors

Samantha K Newman¹, Robert Michael Tuttle¹

Affiliation

¹ Endocrinology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10025, USA.

PMID: 38571308
DOI: 10.1210/clinem/dgae218

No abstract available

PubMed Disclaimer

Comment on

Nonoperative, Active Surveillance of Larger Malignant and Suspicious Thyroid Nodules.
Altshuler B, Bikas A, Pappa T, Marqusee E, Cho NL, Nehs MA, Liu JB, Doherty GM, Landa I, Ahmadi S, Alexander EK. Altshuler B, et al. J Clin Endocrinol Metab. 2024 Jul 12;109(8):1996-2002. doi: 10.1210/clinem/dgae082. J Clin Endocrinol Metab. 2024. PMID: 38349208

Publication types

Actions
Actions

Grants and funding

Memorial Sloan Kettering Cancer Center

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems